4OZAKI T,NISHIMURA N, MUTO T,et al. Safety and immuno- genicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan [ J ]. Vaccine, 2005, 23 ( 10 ) : 1205 - 1208.
6BOOT HJ, DE MELKER HE, STOLK EA, et al. Assessing the introduction of universal varicella vaccination in the Netherlands [J]. Vaccine, 2006, 24(37 -39): 6288 -6299.
7Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices. Update:recommendations from the advisory committee on immunization practices (ACIP) regarding administration of combination MMRV vaccine [ R ]. MMWR Mor Mortal Wkly Rep , 2008, 57(10):258-260.
8OXMAN MN, MD, LEVIN MJ, et al. A Vaccine to prevent her- pes zoster and postherpetic neuralgia in older adults[ J]. N Eng J Med, 2005, 352(20) :2271 -2284.
9ARBETER AM, STARR SE, WEIBEL RE, et al. Live attenua- ted varricella vaccine:the KMcC strain in healthy children [ J ]. Pediatrics, 1983, 71 ( 3 ) :307 - 312.
10WARTON M. The epidemiology of varicella-zoster virus infec- tions[J], Infect Dis Clin NAmer, 1996, 10(3) :571 -581.
